NASDAQ:INCY
Incyte Corporation Stock News
$57.10
+0.240 (+0.422%)
At Close: May 17, 2024
These 3 Biotech Stocks Are Outperforming Their Peers — Here's Why
02:00pm, Tuesday, 07'th Jul 2020
The best biotech companies to invest in tend to have a commonality: a strong streak of earnings growth.
Lonza étend ses capacités dans les techniques de particules | Zone bourse
01:33pm, Wednesday, 01'st Jul 2020How to get loan against mutual fund from ICICI Bank – Check features, eligibility, interest rate
12:04pm, Wednesday, 01'st Jul 2020
The investor need not have to sell the mutual fund units and the loan availed is in the form of overdraft.
Incyte Announces Approval of Tabrecta™ (capmatinib) in Japan for the Treatment of Patients with Advanced Non-Small Cell Lung Cancer with METex14
Wall Street : perd pied avec la pandémie, négatif sur juin
09:51pm, Friday, 26'th Jun 2020Wall Street : Perd pied avec la pandémie, négatif sur juin
09:43pm, Friday, 26'th Jun 2020
(CercleFinance.com) - Wall Street subit une brusque correction qui a pris beaucoup d'opérateurs par surprise: ils s'étaient habitués à ce que les marchés …
Gilead's (GILD) Remdesivir Gets CHMP Approval Recommendation
02:37pm, Friday, 26'th Jun 2020
Gilead's (GILD) experimental coronavirus drug, remdesivir, has been recommended for approval by the EMA's human medicines committee.
MODERNA :signe un contrat de conditionnement de son vaccin avec Catalent | Zone bourse
12:31pm, Thursday, 25'th Jun 2020Maria E. Pasquale Sells 1,423 Shares of Incyte Co. (NASDAQ:INCY) Stock
06:45am, Thursday, 25'th Jun 2020
Incyte Co. (NASDAQ:INCY) EVP Maria E. Pasquale sold 1,423 shares of the business’s stock in a transaction dated Friday, June 19th. The stock was sold at an average price of $100.00, for a total tran
Incyte (NASDAQ:INCY) Shares Up 3.2%
05:38am, Wednesday, 24'th Jun 2020
Incyte Co. (NASDAQ:INCY)’s share price was up 3.2% on Monday . The company traded as high as $106.26 and last traded at $108.76, approximately 110,450 shares were traded during mid-day trading. A de
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 23)
ACADIA Pharmaceuticals Inc...
Gilead to Start Studies for an Inhaled Version of Remdesivir
02:24pm, Tuesday, 23'rd Jun 2020
Gilead (GILD) announces plans to start studies for an inhaled version of the experimental candidate, remdesivir, in August.
The Daily Biotech Pulse: Sanofi Expedites COVID-19 Vaccine Timeline, Apyx Cleared For Market Expansion, Miragen's Positive Readout
12:00am, Tuesday, 23'rd Jun 2020
The following is a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 22)
ADC Therapeutics SA (...
